Contact
Please use this form to send email to PR contact of this press release:
SERB Pharmaceuticals acquires Vistogard® and Xuriden® from Wellstat Therapeutics
TO:
Please use this form to send email to PR contact of this press release:
SERB Pharmaceuticals acquires Vistogard® and Xuriden® from Wellstat Therapeutics
TO: